8.72
price up icon1.16%   0.10
after-market After Hours: 8.83 0.11 +1.26%
loading

Novavax Inc Stock (NVAX) Latest News

pulisher
03:17 AM

Connor Clark & Lunn Investment Management Ltd. Sells 97,515 Shares of Novavax, Inc. (NASDAQ:NVAX) - MarketBeat

03:17 AM
pulisher
Nov 29, 2024

Novavax Inc. stock outperforms competitors on strong trading day - MarketWatch

Nov 29, 2024
pulisher
Nov 29, 2024

Novavax, Inc. (NVAX) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance

Nov 29, 2024
pulisher
Nov 29, 2024

Bank of Montreal Can Buys 517,727 Shares of Novavax, Inc. (NASDAQ:NVAX) - MarketBeat

Nov 29, 2024
pulisher
Nov 29, 2024

Novavax, Inc. (NASDAQ:NVAX) Receives Average Rating of "Hold" from Analysts - MarketBeat

Nov 29, 2024
pulisher
Nov 29, 2024

Nanopharmaceuticals Market Is Booming Worldwide 2024-2031 | - openPR

Nov 29, 2024
pulisher
Nov 27, 2024

Novavax Inc. stock underperforms Wednesday when compared to competitors - MarketWatch

Nov 27, 2024
pulisher
Nov 26, 2024

Novavax Inc. stock underperforms Tuesday when compared to competitors - MarketWatch

Nov 26, 2024
pulisher
Nov 26, 2024

Novavax Cut Its Outlook Despite Beating Third-Quarter Forecasts. Is It A Sell? - Yahoo! Voices

Nov 26, 2024
pulisher
Nov 26, 2024

Novavax and Assembly lead infectious disease gainers in 2024 - BioWorld Online

Nov 26, 2024
pulisher
Nov 22, 2024

Novavax Lowers 2024 Forecast Despite Q3 Revenue Beat, Stock Falls - AOL

Nov 22, 2024
pulisher
Nov 22, 2024

Moderna Stock Jumps Following Bullish Sales View at Healthcare Conference - Investopedia

Nov 22, 2024
pulisher
Nov 22, 2024

Is Biotech’s Bull Run Over? Examining Election Impacts - Investing.com

Nov 22, 2024
pulisher
Nov 21, 2024

Novavax Inc. stock underperforms Thursday when compared to competitors - MarketWatch

Nov 21, 2024
pulisher
Nov 21, 2024

Novavax (STU:NVV1) 5-Year EBITDA Growth Rate : 1.20% (As of Sep. 2024) - GuruFocus.com

Nov 21, 2024
pulisher
Nov 21, 2024

Novavax (STU:NVV1) Revenue per Share : €5.30 (TTM As of Sep. 2024) - GuruFocus.com

Nov 21, 2024
pulisher
Nov 20, 2024

Novavax (HAM:NVV1) Price-to-Owner-Earnings : (As of Nov. 20, 2024) - GuruFocus.com

Nov 20, 2024
pulisher
Nov 20, 2024

Menopause Treatment Market Opportunities, Challenges, - openPR

Nov 20, 2024
pulisher
Nov 20, 2024

Novavax Q3 Earnings & Sales Beat, Stock Falls 6% on '24 View Cut - MSN

Nov 20, 2024
pulisher
Nov 20, 2024

What is B. Riley's Estimate for Novavax FY2024 Earnings? - MarketBeat

Nov 20, 2024
pulisher
Nov 20, 2024

Novavax to Present at Jefferies London Conference - TipRanks

Nov 20, 2024
pulisher
Nov 20, 2024

Novavax in $123.8M settlement with U.K. agency over COVID vaccine deal - MSN

Nov 20, 2024
pulisher
Nov 20, 2024

Preventive Vaccines Market May Set New Growth Story | Takeda - openPR

Nov 20, 2024
pulisher
Nov 18, 2024

Health Care Flat After Last Week's SelloffHealth Care Roundup - Marketscreener.com

Nov 18, 2024
pulisher
Nov 18, 2024

Investors Heavily Search Novavax, Inc. (NVAX): Here is What You Need to Know - Yahoo Finance

Nov 18, 2024
pulisher
Nov 18, 2024

How To Trade (NVAX) - Stock Traders Daily

Nov 18, 2024
pulisher
Nov 18, 2024

FY2024 Earnings Forecast for Novavax Issued By HC Wainwright - MarketBeat

Nov 18, 2024
pulisher
Nov 15, 2024

Novavax Inc. stock underperforms Friday when compared to competitors despite daily gains - MarketWatch

Nov 15, 2024
pulisher
Nov 15, 2024

Big Pharma Stocks Drop After RFK Jr. Announced as Health Secretary - Newsweek

Nov 15, 2024
pulisher
Nov 15, 2024

UK regulator approves adapted Novavax jab - The Pharma Letter

Nov 15, 2024
pulisher
Nov 15, 2024

Health stocks slide as Trump picks vaccine skeptic Kennedy - Los Angeles Times

Nov 15, 2024
pulisher
Nov 15, 2024

Moderna, Novavax stocks slide after Trump nominates Robert F. Kennedy Jr. to be top health official - Yahoo Finance

Nov 15, 2024
pulisher
Nov 15, 2024

Vaccine maker stocks fall after conspiracy theory-spreading RFK Jr. tapped to lead health department - New York Post

Nov 15, 2024
pulisher
Nov 15, 2024

Shot Down: Vaccine stocks tumble with RFK Jr. as Health SecretaryFinbold - Finbold - Finance in Bold

Nov 15, 2024
pulisher
Nov 15, 2024

Robert F. Kennedy Jr.’s Billion-Dollar Hit to Big Pharma - The New York Times

Nov 15, 2024
pulisher
Nov 15, 2024

Health Stocks Slide as Trump Picks Vaccine Skeptic Kennedy - Yahoo Finance

Nov 15, 2024
pulisher
Nov 15, 2024

Novavax, Inc. (NASDAQ:NVAX) Just Reported, And Analysts Assigned A US$16.67 Price Target - Simply Wall St

Nov 15, 2024
pulisher
Nov 15, 2024

Moderna, Lily, Novavax, and Pfizer stocks fall after Trump nominates RFK Jr. as health secretary - Fast Company

Nov 15, 2024
pulisher
Nov 15, 2024

Novavax Announces Grant of Inducement Awards Pursuant to Nasdaq Listing Rule 5635(c)(4) - The Malaysian Reserve

Nov 15, 2024
pulisher
Nov 15, 2024

Vaccine Stocks Fall After Trump Selects RFK Jr. to Lead HHS - Yahoo Finance

Nov 15, 2024
pulisher
Nov 15, 2024

WHO Calls Vaccines 'Absolutely Critical' As Trump's Appointment Of RFK Jr Pulls Pzifer, Moderna Stocks Downhill - Benzinga

Nov 15, 2024
pulisher
Nov 15, 2024

Moderna, Novovax stocks slide after Trump nominates Robert F. Kennedy Jr. to be top health official - Yahoo Finance

Nov 15, 2024
pulisher
Nov 15, 2024

Novavax, Inc. (NASDAQ:NVAX) Just Reported Earnings, And Analysts Cut Their Target Price - Yahoo Finance

Nov 15, 2024
pulisher
Nov 15, 2024

Trump Taps Vaccine Skeptic RFK Jr. to Lead HHS. Moderna, Novavax Stock Slide. - Barron's

Nov 15, 2024
pulisher
Nov 15, 2024

Vaccine Maker Stocks Fall After Trump Taps RFK Jr. to Head HHS - MSN

Nov 15, 2024
pulisher
Nov 14, 2024

Vaccine maker stocks tumble after Trump picks RFK Jr. for health secretary - CNN

Nov 14, 2024
pulisher
Nov 14, 2024

Moderna, Novavax Shares Slip After Trump Names RFK Jr. Health Chief Nominee - Wall Street Pit

Nov 14, 2024
pulisher
Nov 14, 2024

Big Pharma stocks tumble as Trump nominates RFK Jr. to lead HHS - The National Desk

Nov 14, 2024
pulisher
Nov 14, 2024

Trump Taps RFK Jr. For Health Secretary Role, Sends 5 Vaccine Stocks Lower - Benzinga

Nov 14, 2024
pulisher
Nov 14, 2024

Biotech Stock Roundup: NVAX Q3 Results, SNDX Down on AML Data, RNA Surges on Study Data - Yahoo Finance

Nov 14, 2024
pulisher
Nov 14, 2024

Novavax to Participate in Jefferies London Healthcare Conference - StreetInsider.com

Nov 14, 2024
pulisher
Nov 14, 2024

Novavax Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance

Nov 14, 2024
pulisher
Nov 13, 2024

Novavax Lowers 2024 Revenue Forecast Due To Weak Vaccine Sales - Finimize

Nov 13, 2024
$21.50
price up icon 1.61%
$74.59
price down icon 1.14%
$370.49
price down icon 2.02%
$43.06
price down icon 0.76%
$215.00
price up icon 4.29%
$118.39
price down icon 1.93%
Cap:     |  Volume (24h):